Article Details

TrialJectory Achieves 500 Percent Year-Over-Year Growth as Cancer Patients and Pharmaceutical ...

Retrieved on: 2021-03-09 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

TrialJectory Achieves 500 Percent Year-Over-Year Growth as Cancer Patients and Pharmaceutical .... View article details on HISWAI: https://www.prnewswire.com/news-releases/trialjectory-achieves-500-percent-year-over-year-growth-as-cancer-patients-and-pharmaceutical-industry-increasingly-leverage-proprietary-ai-platform-in-covid-19-pandemic-301243000.html

Excerpt

... with equal participation from Rho Ventures. Connecticut Innovations and TIA Ventures also participated in the $5 million round. To date, TrialJectory ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up